Evaluation of HGF and endostatin in the bone marrow of patients with multiple myeloma and the effect of peripheral blood admixture

Scripta Medica Facultatis Medicae Universitatis Brunensis Masarykianae

Volumn 82, Issue 2, 2009, Pages 123-126

  Pour, L ^a   Kovarova L ^a   Buchler, T ^a   Adam, Z ^a   Penka, M ^a   Vorlicek J ^a   Hajek R ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Endostatin; HGF; Multiple myeloma

Indexed keywords

ENDOSTATIN; SCATTER FACTOR;

ADULT; ARTICLE; BLOOD; BONE MARROW; CANCER PATIENT; CLINICAL ARTICLE; EVALUATION; FEMALE; HUMAN; MALE; MULTIPLE MYELOMA; MYELOMA CELL; PROTEIN SECRETION; SAMPLING; STANDARDIZATION;

EID: 67649628473     PISSN: 12113395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Vacca A, Ribatti D, Roccaro AM, et al. Bone marrow angiogenesis in patients with active multiple myeloma. Semin Oncol 2001; 28: 543-550. (Pubitemid 33134413)
2. Batinic D, Marusic M, Pavletic Z, et al. Relationship between differing volumes of bone marrow aspirates and their cellular composition. Bone Marrow Transplant 1990; 6: 103-107. (Pubitemid 20270757)
3. Abrahamsen JF, Smaaland R, Skjaerven R, Laerum OD. Flow cytometric measurement of DNA S-phase in human bone marrow cells: correcting for peripheral blood contamination. Eur J Haematol 1996; 56: 38-47. (Pubitemid 26094070)
4. Alexandrakis MG, Passam FH, Sfiridaki A, Kandidaki E, Roussou P, Kyriakou DS. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity. Am J Hematol 2003; 72: 229-233. (Pubitemid 36383972)
5. Sezer O, Jakob C, Eucker J, Niemoller K, Gatz F, Wernecke K. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma. Eur J Haematol 2001; 66: 83-88. (Pubitemid 32154100)
6. Neben K, Moehler T, Kraemer A, et al. Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion. Br J Haematol 2001; 115: 605-608. (Pubitemid 34015650)
7. Voest E, D'Amore P. Tumor angiogenesis and microcirculation. New York: Marcel Dekker AG, 2001.
8. Urbanska-Rys H, Robak T. High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment. Mediators Inflamm 2003; 12(4): 229-235. (Pubitemid 37297192)
9. Di Raimondo F, Azzaro MP, Palumbo G, et al. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Haematologica 2000; 85: 800-805.